These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34144510)

  • 1. Assessment of multiple salivary biomarkers during repetitive transcranial magnetic stimulation (rTMS) treatment for major depression.
    See RE; Eusebio B; Agnew D; Heatwole M
    Psychiatry Res; 2021 Aug; 302():114053. PubMed ID: 34144510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers.
    Corlier J; Tadayonnejad R; Wilson AC; Lee JC; Marder KG; Ginder ND; Wilke SA; Levitt J; Krantz D; Leuchter AF
    Psychol Med; 2023 Feb; 53(3):823-832. PubMed ID: 34154683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular biomarkers of response to accelerated low frequency repetitive transcranial magnetic stimulation in major depression.
    Sheen JZ; Miron JP; Mansouri F; Dunlop K; Russell T; Zhou R; Hyde M; Fox L; Voetterl H; Daskalakis ZJ; Griffiths JD; Blumberger DM; Downar J
    J Affect Disord; 2022 Dec; 318():167-174. PubMed ID: 36055538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder.
    Carpenter LL; Conelea C; Tyrka AR; Welch ES; Greenberg BD; Price LH; Niedzwiecki M; Yip AG; Barnes J; Philip NS
    J Affect Disord; 2018 Aug; 235():414-420. PubMed ID: 29677606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Nishida M; Kikuchi S; Nisijima K; Suda S
    J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of quantitative electroencephalograms following prefrontal repetitive transcranial magnetic stimulation in patients with major depression.
    Noda Y; Nakamura M; Saeki T; Inoue M; Iwanari H; Kasai K
    Neurosci Res; 2013; 77(1-2):70-7. PubMed ID: 23827366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder.
    White D; Tavakoli S
    Ann Clin Psychiatry; 2015 Aug; 27(3):192-6. PubMed ID: 26247218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.
    Tadayonnejad R; Wilson AC; Chu SA; Corlier J; Citrenbaum C; Ngo TDP; Hovhannisyan E; Ginder ND; Levitt JG; Wilke SA; Krantz D; Bari AA; Leuchter AF
    Psychiatry Res; 2022 Nov; 317():114856. PubMed ID: 36155277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of machine learning in predicting the efficacy of repetitive transcranial magnetic stimulation on treating depression based on functional and structural thalamo-prefrontal connectivity: A pilot study.
    Chen D; Lei X; Du L; Long Z
    J Psychiatr Res; 2022 Apr; 148():88-94. PubMed ID: 35121273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
    Kobayashi B; Cook IA; Hunter AM; Minzenberg MJ; Krantz DE; Leuchter AF
    Int Rev Psychiatry; 2017 Apr; 29(2):98-114. PubMed ID: 28362541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive transcranial magnetic stimulation (rTMS) is associated with increased abstinence in substance use disorders and comorbid depression.
    Foad W; Aziz KA; Agour M; Ali A; Alhammadi F; Alhawi R; Altamimi S; Hussain Z; Aty AA; Qassem T
    Ann Clin Psychiatry; 2023 Feb; 35(1):31-38. PubMed ID: 36716467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain oscillation-synchronized stimulation of the left dorsolateral prefrontal cortex in depression using real-time EEG-triggered TMS.
    Zrenner B; Zrenner C; Gordon PC; Belardinelli P; McDermott EJ; Soekadar SR; Fallgatter AJ; Ziemann U; Müller-Dahlhaus F
    Brain Stimul; 2020; 13(1):197-205. PubMed ID: 31631058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy.
    Pathak Y; Salami O; Baillet S; Li Z; Butson CR
    Front Neural Circuits; 2016; 10():50. PubMed ID: 27524960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.